H.R. 796 — Second Chance for Moms Act

This section amends the Federal Food, Drug, and Cosmetic Act to deem mifepristone misbranded unless its labeling bears a conspicuous warning statement that medical evidence suggests natural progesterone can counteract its abortifacient effects—increasing chances of fetal survival—and that such progesterone is safe in the first trimester per the American Society for Reproductive Medicine, along with a specified hotline number; the requirement applies beginning 6 months after enactment. The section further amends Title X of the Public Health Service Act to direct the Secretary of Health and Human Services to establish or maintain a toll-free hotline, available 24 hours a day, 7 days a week, to support women seeking to reverse mifepristone's effects, with referrals limited to health care providers offering abortion pill reversal services.